Bluestar Adisseo Co (600299)
Shanghai Stock Exchange · China · prices in CNY · close of 21 Oct 2026
Key indicators
| Last close | CNY 8.080 |
|---|---|
| 52-week range | 7.582 – 16.480 |
| Return, 1 month / 3 months | −5.4% / −1.7% |
| Return, 1 year / 3 years | −14.2% / −0.4% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 41.3% |
| Worst drawdown (1 year) | -49.9% |
| Average daily value traded | 295.52M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bluestar Adisseo Co is an animal nutrition company that makes feed additives for livestock and poultry. Its products include methionine, vitamins and other nutritional ingredients used by feed producers and farmers to support animal health and growth. The business serves customers in the feed and livestock industries across many countries, and its operations are based in France with ownership linked to Chinese chemical group Bluestar.
The shares are listed on the Shanghai Stock Exchange in China under the code 600299, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bluestar Adisseo Co (600299) trades on the Shanghai Stock Exchange in China. It last closed at CNY 8.080 on 21 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 1,563 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.2% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.0% | ||
| From 52-week high | -47.7% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -46.7% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.9% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 295.52M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | −5.4% |
| 3 months | −1.7% |
| 6 months | −46.7% |
| 1 year | −14.2% |
| 3 years | −0.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.405 / 10.233 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.224 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2023 | CNY 0.1510 |
| 20 Jun 2022 | CNY 0.1780 |
| 17 Jun 2021 | CNY 0.1760 |
| 12 Jun 2020 | CNY 0.1560 |
| 19 Dec 2019 | CNY 0.1030 |
| 13 Jun 2019 | CNY 0.1730 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.